- Country: Brazil
- Summary: Acquisition of 50mg Bicalutamide and Others
- BRT Ref No: 63182980
- Deadline: 23 Feb 2022
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 73/2022
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Object: Electronic Town - Bicalutamide acquisition 50mg and other
UASG Code: 250052
Notice from 02/11/2022 from 09:00 to 4:00 p.m. Delivery of the proposal: from 11/02/2022 at 09:00 p.m. Bicalutamide, Dosage 50 mg Quantity: 1000
Chlorambucila, dosage 2 mg Quantity: 2500
DasAtinib, concentration 100 mg Quantity: 1200
DasAtinib, concentration 20 mg Quantity: 1200
Everolimo, concentration 2.5 mg Quantity: 900
Melphalana, dosing 2 mg Quantity: 1000
Mitotane, concentration 500 mg Quantity: 9000
Nilotinib, concentration 200 mg Quantity: 10000 Vinorelbina, composition salt tartarato, concentration 20 mg Quantity: 300 - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAcquisition of 50mg Bicalutamide and Others - Brazil Tender
The MINISTRY OF HEALTH, a Government sector organization in Brazil, has announced a new tender for Acquisition of 50mg Bicalutamide and Others. This tender is published on BrazilTenders under BRT Ref No: 63182980 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-02-23.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
